Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T18:55:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the updates relate to study status and contacts/locations within the record.
    Difference
    0.1%
    Check dated 2026-03-04T15:30:50.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page history. No study data or essential content was altered.
    Difference
    0.1%
    Check dated 2026-02-11T10:59:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-04T10:23:47.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page history and v3.3.3 was removed; no user-facing study information appears to change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:00:05.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:27:09.000Z thumbnail image

Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.